Dr. Rafiq Hasan

NLSDays 2021 is a great opportunity to learn about the strong innovation emerging from the Nordics, as well as to share experiences and best practices,”


EXACT-Tx is a clinical stage Anglo-Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. www.exact-tx.com


Opening Plenary 20 April 9:30 CET

Opening Plenary